Venue / Journal
2022 08 31; 14(660):eabj1531.
Authors
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
Pubmed URL
http://www.ncbi.nlm.nih.gov/pubmed/36044597